Expertise in
1
conditions

Dr. Kurt Griffin

Pediatric Endocrinology
Sanford Children's Hospital Sioux Falls
1600 W 22nd St, 
Sioux Falls, SD 
Clinical Trials:Currently Recruiting for 1 Trial
Referral may be required
Expertise in
1
conditions
Sanford Children's Hospital Sioux Falls
1600 W 22nd St, 
Sioux Falls, SD 

Overview

Kurt Griffin is a Pediatric Endocrinologist practicing medicine in Sioux Falls, South Dakota.

Dr. Griffin is highly rated in 1 condition, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Diabetic Ketoacidosis.

He is actively involved in clinical research, co-authoring 24 peer reviewed articles and participating in 6 clinical trials.

Specialties

Pediatric Endocrinology

Licenses

Pediatric Endocrinology in AZ

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Primewest Health System
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Sanford
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Sanford Health
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellmark
  • HMO
  • POS
View 6 Less Insurance Carriers -

Locations

Sanford Children's Hospital Sioux Falls
1600 W 22nd St, Sioux Falls, SD 57105

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Type 1 Diabetes Extension Study
Type 1 Diabetes Extension Study
Enrollment Status: Recruiting
Publish Date: March 10, 2026
Multi-center, Randomized, Parallel, Adaptive, Controlled Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control (CSII, MDI and SAP) at Home
Multi-center, Randomized, Parallel, Adaptive, Controlled Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control (CSII, MDI and SAP) at Home
Enrollment Status: Completed
Publish Date: August 19, 2025
Intervention Type: Device
Study Phase: Not Applicable
Hydroxychloroquine for Prevention of Abnormal Glucose Tolerance and Diabetes in Individuals At-risk for Type 1 Diabetes Mellitus (T1D)
Hydroxychloroquine for Prevention of Abnormal Glucose Tolerance and Diabetes in Individuals At-risk for Type 1 Diabetes Mellitus (T1D)
Enrollment Status: Terminated
Publish Date: April 09, 2024
Intervention Type: Drug
Study Drug: Hydroxychloroquine
Study Phase: Phase 2
A Prospective, Multi-center, Phase 1b/2a Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Association With Teplizumab in Patients With Clinical Recent-onset Type 1 Diabetes Mellitus (T1D)
A Prospective, Multi-center, Phase 1b/2a Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Association With Teplizumab in Patients With Clinical Recent-onset Type 1 Diabetes Mellitus (T1D)
Enrollment Status: Completed
Publish Date: February 01, 2023
Intervention Type: Biological, Drug
Study Drugs: AG019 - Low Dose, Teplizumab, AG019 - High Dose, AG019 - Low or High Dose
Study Phase: Phase 1/Phase 2
Preserving Beta-Cell Function With Tocilizumab in New-onset Type 1 Diabetes (ITN058AI)
Preserving Beta-Cell Function With Tocilizumab in New-onset Type 1 Diabetes (ITN058AI)
Enrollment Status: Completed
Publish Date: September 08, 2021
Intervention Type: Drug, Other
Study Phase: Phase 2
A Prospective Randomized Placebo-Controlled Double Blind Clinical Trial to Evaluate the Safety and Efficacy of CLBS03 (Autologous Ex Vivo Expanded Polyclonal Regulatory T-cells) in Adolescents With Recent Onset Type 1 Diabetes Mellitus (T1DM)
A Prospective Randomized Placebo-Controlled Double Blind Clinical Trial to Evaluate the Safety and Efficacy of CLBS03 (Autologous Ex Vivo Expanded Polyclonal Regulatory T-cells) in Adolescents With Recent Onset Type 1 Diabetes Mellitus (T1DM)
Enrollment Status: Completed
Publish Date: January 08, 2021
Intervention Type: Biological
Study Phase: Phase 2
View 5 Less Clinical Trials

24 Total Publications

Automated basal insulin delivery versus multiple daily injections in type 1 diabetes: results from a randomized parallel controlled trial.
Automated basal insulin delivery versus multiple daily injections in type 1 diabetes: results from a randomized parallel controlled trial.
Journal: Frontiers in endocrinology
Published: September 30, 2025
Similar Doctors
Expertise in
1
conditions
Dr. Laura Davis
Pediatric Endocrinology | Medical Genetics
Expertise in
1
conditions
Dr. Laura Davis
Pediatric Endocrinology | Medical Genetics
Referral may be required

Sanford Imagenetics

1321 W. 22nd St., 
Sioux Falls, SD 
 (0.1 miles away)
605-404-4000
Languages Spoken:
English
See accepted insurances

Dr. Laura Davis-Keppen specializes in genetic conditions, birth defects, developmental and growth concerns and metabolic conditions. Dr. Davis is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Pompe Disease, Syndactyly Type 1, Urea Cycle Disorders (UCD), and Turner Syndrome. Dr. Davis is board certified in American Board Of Medical Genetics: Clinical GeneticsAmerican Board Of Pediatrics: Pediatric EndocrinologyAmerican Board Of Pediatrics: Pediatrics.

Expertise in
0
conditions
Dr. John Shelso
Pediatric Endocrinology
Expertise in
0
conditions
Dr. John Shelso
Pediatric Endocrinology
Referral may be required

Sanford Children's Hospital Sioux Falls

1600 W 22nd St, 
Sioux Falls, SD 
 (0.1 miles away)
605-333-1000
Languages Spoken:
English
See accepted insurances

John Shelso is a Pediatric Endocrinologist practicing medicine in Sioux Falls, South Dakota. His clinical expertise encompasses Type 1 Diabetes (T1D) and Septo-Optic Dysplasia.

Expertise in
0
conditions
Dr. Ashutosh Gupta
Pediatric Endocrinology
Expertise in
0
conditions
Dr. Ashutosh Gupta
Pediatric Endocrinology
Referral may be required

Avera Medical Group Pediatric Specialists — Plaza 1

1417 S Cliff Ave Plaza 1, Suites 010 & 101 A, 
Sioux Falls, SD 
 (1.0 miles away)
605-322-3666
Languages Spoken:
English
See accepted insurances

Dr. Ashutosh Gupta is a pediatric endocrinologist at Avera Medical Group Pediatric Specialists Sioux Falls. His clinical expertise encompasses Idiopathic Short Stature (ISS), Familial Short Stature (FSS), Short Stature (Growth Disorders), and Type 1 Diabetes (T1D). Dr. Gupta is board certified in American Board Of Pediatrics Subspecialty Board Of Endocrinology.

Frequently Asked Questions about Dr. Kurt Griffin

How do I make an appointment with Dr. Kurt Griffin?

You can book an appointment with Dr. Kurt Griffin by calling their office at 605-312-1000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Kurt Griffin a top-rated expert for Type 1 Diabetes (T1D)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kurt Griffin is classified as an Advanced expert for Type 1 Diabetes (T1D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Kurt Griffin specialize in?

While Dr. Kurt Griffin is a Pediatric Endocrinology, they have specific expertise in Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Diabetic Ketoacidosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Endocrinology.

Does Dr. Kurt Griffin participate in research or clinical trials?

Yes. Dr. Kurt Griffin has published 24 articles and abstracts on conditions like Type 1 Diabetes (T1D). You can view a list of Dr. Kurt Griffin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Kurt Griffin accept my insurance?

Dr. Kurt Griffin accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 605-312-1000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Griffin's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile